Moreover, a statistically significant correlation between better response to neoadjuvant therapy and increased CD4+ and CD8+ T-cell infiltration in pretreatment rectal cancer biopsies was demonstrated [37,38]. The gene discussed is CD8A; the disease is rectal cancer.